Bristol-Myers Squibb Company ( NYSE: BMY) is scheduled to announce Q2 earnings results on July 31st, before markets open.

The new direct-to-consumer ad signals J&J’s confidence in its capacity to meet demand for the cell therapy after earlier ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

Itching is often the most debilitating cutaneous symptom of CKD and ESRD. Experts recommend a stepwise treatment approach ...

AstraZeneca's CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...

Bristol-Myers Squibb unveils its earnings this Thursday. Last quarter, they beat revenue estimates by nearly 4%. Now, ...

AI-powered quantification of tumor-infiltrating lymphocytes could change how patients with melanoma are treated after surgery ...

You also don't need a substantial amount of money on hand to invest. Here are three prominent healthcare companies you can ...

From concerning statistics on global health outcomes to new insights on AI and RWD, explore the top pharma news from July ...

Multiple myeloma pathogenesis is marked by incredibly complex processes that range beyond primary or acquired genetic alterations, with factors in the ...

Two diabetes drugs could become more affordable for Maryland residents, following a study by the Prescription Drug ...